Category: Politics and Regulation

Gender-affirming care is not “experimental”
Gender-affirming care remains the evidence-based standard of care for gender dysphoria in transgender adolescents, despite claims by some laws and lawmakers that it is “experimental”.

Medical debt vs. universal health insurance: The interface between SBM and policy
This blog has long argued that the best medicine is science-based medicine (SBM). The problem is that in the US SBM is often not accessible, except at ruinous cost, which is why I argue that we have to broaden our definition of SBM to include the systems that deliver it and pay for it.

The ABIM vs. medical misinformation: Better late than never?
Last week, the New England Journal of Medicine published an editorial by the President of ABIM discussing how the board certification can be taken away from diplomates who spread medical misinformation. Is this too little, too late?

Ayn Rand, Objectivists, and COVID
Healthcare workers are leaving medicine after coming under attack due to the type of disinformation spread by Objectivists. That's ironic.

Vaccines Don’t Save Lives
Fostering basic critical thinking skills and countering medical misinformation is a vital undertaking.

Columbia University finally cuts ties with America’s Quack Dr. Oz
Decades after Dr. Oz pioneered "integrating" quackery into medicine and after many years of promoting diet scams and quackery on a nationally syndicated daily television show, Columbia University appears finally to have had enough and has quietly downgraded his status. What took so long?
Federal employment rights agency inundated with thousands of COVID-related discrimination claims
Thousands of workers have filed complaints with the EEOC alleging COVID-related employment discrimination. It may take years of litigation to sort out the application of federal anti-bias laws to these claims.

State Attorneys General pursue consumer protection law claims against stem cell clinics
State Attorneys General are pursuing stem cell clinics offering unproven therapies and engaging in fake clinical trials using state consumer protection and false advertising laws, seeking monetary penalties and injunctive relief. Until there is rational, comprehensive stem cell regulation, these actions can help fill the regulatory gap.

Good faith doctoring or greedy drug dealing? SCOTUS hears opioid prescribing cases
Physicians running opioid "pill mills" were convicted of violating the Controlled Substances Act and given substantial prison sentences. The U.S. Supreme Court will soon decide whether they were entitled to a "good faith" defense at trial.